Showing results (1011-1020 of 1,155) with videos related to
Sort By:
Pageof 116
The British Journal of Surgery|May 27, 2023
Locally recurrent rectal cancer: Oncological outcomes for patients with a pathological complete response after neoadjuvant therapyStefi Nordkamp, Floor Piqeur, Kim van den Berg, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: first-line interventionsA Karam, J A Ledermann, J-W Kim, et al.The British Journal of Surgery|March 27, 2023
Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD)Sofieke J D Temmink, Koen C M J Peeters, Renu R Bahadoer, et al.Vaccine|December 25, 2025
Antibody concentration and function following SARS-CoV-2 vaccination decrease with age in adults and children with Down syndromeBianca M M Streng, Lobke C M Hensen, Eveline M Delemarre, et al.British Journal of Haematology|October 23, 2015
Minimal residual disease assessed by multi-parameter flow cytometry is highly prognostic in adult patients with acute lymphoblastic leukaemiaFarhad Ravandi, Jeffrey L Jorgensen, Susan M O'Brien, et al.Radiation Oncology (London, England)|December 23, 2025
Neoadjuvant chemo-reirradiation followed by resection and intraoperative electron beam radiotherapy: outcomes of multimodality treatment for locally recurrent rectal cancerF E C Vande Kerckhove, F Piqeur, E Banken, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
Preclinical and early clinical evaluation of the oral AKT inhibitor, MK-2206, for the treatment of acute myelogenous leukemiaMarina Y Konopleva, Roland B Walter, Stefan H Faderl, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2024
Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group StudyCharles N Landen, Ronald J Buckanovich, Michael W Sill, et al.JAMA Oncology|January 1, 2016
Inherited Mutations in Women With Ovarian CarcinomaBarbara M Norquist, Maria I Harrell, Mark F Brady, et al.Cell Reports|August 30, 2018
Rapid and Integrative Discovery of Retina Regulatory MoleculesNicholas E Albrecht, Jonathan Alevy, Danye Jiang, et al.Pageof 116